Follow us
Nigeria Health Watch
Follow us:
Subscribe to our Newsletter
breadcrumb banner

Press Release

Official health announcements from Nigeria, Africa, and around the world. We publish press releases on new research, policy decisions, campaigns, events, and major health reports that shape priorities and public debate. This space helps practitioners, advocates, and decision makers track what is being launched, funded, recommended, or changed, and why it matters for people’s health. If you would like us to consider your press release for publication, please email it to info@nigeriahealthwatch.com.

Search

Categories

Recent Posts

Post Image

As Efforts Intensify to Contain Bundibugyo Ebola, Women Remain Most Vulnerable to Its Economic Impact

Jul 06, 2026
Post Image

An Epidemic of Parastatals in Nigeria’s Health Sector

Jul 04, 2026
Post Image

From Innovation to Integration: What It Will Take to Make Every Pregnancy Safer in Nigeria

Jul 03, 2026
Post Image

Community Feedback Prompts PHC Upgrade in Gauraka, Niger State

Jul 03, 2026
Post Image

Why Zambia is Rethinking Tuberculosis Testing, and Why Validation Must Come First

Jul 02, 2026
Blog Image 4 Feb

West Africa Takes Historic Step Toward Lassa Fever Vaccine Access with Launch of First End-to-End Roadmap

By Nigeria Health Watch | February 4, 2026

West Africa has today, 3rd February 2026, marked a major milestone in regional health security with the official launch of the Lassa Fever End-to-End (E2E) Access Roadmap for West Africa, a first-of-its-kind, regionally-led framework designed to ensure equitable access to safe and effective Lassa fever vaccines once they become available. The roadmap was developed with […]

Read More
Blog Image 23 Jan

CEPI backs updated Zaire ebolavirus vaccine that aims to improve vaccine affordability and accessibility for low- and middle-income countries

By Nigeria Health Watch | January 23, 2026

GENEVA/OSLO/21 JAN: A vaccine used to help protect against Zaire ebolavirus – one of the world’s most severe infectious diseases – could become more affordable and easier to deploy in low-resource settings thanks to a new collaboration between CEPI and MSD. Backed by up to $30 million in CEPI funding, MSD will leverage Hilleman Laboratories, a joint […]

Read More
Blog Image 13 Jan

Oxford University enters into licensing arrangement with Serum Institute of India to develop Rift Valley fever vaccine candidate

By Nigeria Health Watch | January 13, 2026

Serum Institute of India to make up to 100,000 investigational Oxford Rift Valley fever vaccine doses. Rift Valley fever is a potentially deadly viral disease currently affecting West Africa. Doses manufactured by Serum Institute of India could be set aside for testing to combat the outbreak and future Rift Valley fever emergencies. The epidemic preparedness […]

Read More
Blog Image 20 Dec

NIGERIA AND UNITED STATES SIGN LANDMARK AGREEMENT TO STRENGTHEN HEALTH SECURITY, EXPAND PRIMARY CARE, AND DRIVE SELF-RELIANCE

By Nigeria Health Watch | December 20, 2025

The Government of the Federal Republic of Nigeria and the Government of the United States of America today signed a landmark technical Memorandum of Understanding (MoU) to deepen bilateral health cooperation, strengthen health security, and build a more resilient and self-reliant health system for Nigerians. The agreement will enhance collaboration on the early detection, prevention, […]

Read More
Blog Image 4 Dec

First Volunteer Receives Lassa Fever Vaccine in Cutting-edge Oxford Trial

By Nigeria Health Watch | December 4, 2025

The first volunteer has received a dose in a first-in-human trial of a Lassa vaccine, marking a major milestone in the fight against the deadly virus. The trial, conducted by the Oxford Vaccine Group, and funded by the Coalition for Epidemic Preparedness Innovations (CEPI), will assess the safety and immune response of the ChAdOx1 Lassa […]

Read More